• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

汇聚力量，改善药品可及性：东非共同体药品监管协调倡议的缘起。

Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.

机构信息

World Health Organization, Geneva, Switzerland.

African Union Development Agency-New Partnership for Africa's Development, Midrand, South Africa.

出版信息

PLoS Med. 2020 Aug 12;17(8):e1003133. doi: 10.1371/journal.pmed.1003133. eCollection 2020 Aug.

DOI:10.1371/journal.pmed.1003133
PMID:32785273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7423075/
Abstract

Hiiti Sillo and colleagues reveal how the East African Community's Medicines Regulatory Harmonization initiative improves access to important medicines in Africa.

摘要

希提·西洛（Hiiti Sillo）及其同事揭示了东非共同体药品监管协调倡议如何改善非洲获得重要药品的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/8aef6230f463/pmed.1003133.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/9215123316f1/pmed.1003133.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/8973373702b8/pmed.1003133.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/a4d4c2708fbc/pmed.1003133.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/8aef6230f463/pmed.1003133.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/9215123316f1/pmed.1003133.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/8973373702b8/pmed.1003133.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/a4d4c2708fbc/pmed.1003133.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ef/7423075/8aef6230f463/pmed.1003133.g004.jpg

相似文献

1
Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.汇聚力量，改善药品可及性：东非共同体药品监管协调倡议的缘起。
PLoS Med. 2020 Aug 12;17(8):e1003133. doi: 10.1371/journal.pmed.1003133. eCollection 2020 Aug.
2
Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.提高东非获得高质量药物的机会：对东非共同体药品监管协调倡议的独立看法。
PLoS Med. 2020 Aug 12;17(8):e1003092. doi: 10.1371/journal.pmed.1003092. eCollection 2020 Aug.
3
Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future.2020-2022 年优化东非共同体药品监管协调倡议：未来路线图。
PLoS Med. 2020 Aug 12;17(8):e1003129. doi: 10.1371/journal.pmed.1003129. eCollection 2020 Aug.
4
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.东非共同体药品监管协调倡议八年：实施、进展和经验教训。
PLoS Med. 2020 Aug 12;17(8):e1003134. doi: 10.1371/journal.pmed.1003134. eCollection 2020 Aug.
5
A new approach to an old problem: Overview of the East African Community's Medicines Regulatory Harmonization initiative.解决老问题的新方法：东非共同体药品监管协调倡议概述
PLoS Med. 2020 Aug 12;17(8):e1003099. doi: 10.1371/journal.pmed.1003099. eCollection 2020 Aug.
6
Industrial perceptions of medicines regulatory harmonization in the East African Community.东非共同体中对药品监管协调的产业看法。
PLoS One. 2019 Jun 19;14(6):e0218617. doi: 10.1371/journal.pone.0218617. eCollection 2019.
7
Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative.对当前东非共同体药品监管协调联合审查程序的建议改进以及该倡议的新审查模式提案。
Pharmaceut Med. 2025 Mar;39(2):125-141. doi: 10.1007/s40290-025-00554-1. Epub 2025 Mar 4.
8
The African medicines regulatory harmonization initiative: rationale and benefits.非洲药品监管协调倡议：原理与效益。
Clin Pharmacol Ther. 2011 Feb;89(2):176-8. doi: 10.1038/clpt.2010.299.
9
Strengthening access to cancer medicines for children in East Africa: policy options to enhance medicine procurement, forecasting, and regulations.加强东非儿童获得癌症药物的机会：增强药物采购、预测和监管的政策选择。
Glob Health Res Policy. 2024 Jul 1;9(1):24. doi: 10.1186/s41256-024-00365-y.
10
The early access to medicines scheme.药品早期准入计划。
Br J Hosp Med (Lond). 2014 Aug;75(8):424-5. doi: 10.12968/hmed.2014.75.8.424.

引用本文的文献

1
Comparison of the review models and regulatory timelines of seven countries participating in the ECOWAS-MRH initiative: identifying opportunities for improvement.参与西非国家经济共同体-疟疾研究与培训联盟倡议的七个国家的审评模式和监管时间表比较：确定改进机会
Front Med (Lausanne). 2025 Jul 14;12:1587761. doi: 10.3389/fmed.2025.1587761. eCollection 2025.
2
Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative.对当前东非共同体药品监管协调联合审查程序的建议改进以及该倡议的新审查模式提案。
Pharmaceut Med. 2025 Mar;39(2):125-141. doi: 10.1007/s40290-025-00554-1. Epub 2025 Mar 4.
3

本文引用的文献

1
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.东非共同体药品监管协调倡议八年：实施、进展和经验教训。
PLoS Med. 2020 Aug 12;17(8):e1003134. doi: 10.1371/journal.pmed.1003134. eCollection 2020 Aug.
2
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.加快低收入和中等收入国家的疫苗及药品获取：变革的理由与优化产品市场授权框架
PLoS One. 2016 Nov 16;11(11):e0166515. doi: 10.1371/journal.pone.0166515. eCollection 2016.
3
Establishing links between drug registers and essential medicines lists.
在药品登记册与基本药物清单之间建立联系。
Bull World Health Organ. 2025 Jan 1;103(1):37-42. doi: 10.2471/BLT.24.291512. Epub 2024 Oct 29.
4
Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978-2020.加强坦桑尼亚医疗产品监管：1978 - 2020年监管能力发展评估
PLOS Glob Public Health. 2024 Oct 16;4(10):e0003241. doi: 10.1371/journal.pgph.0003241. eCollection 2024.
5
Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment.比较非洲的三种区域药品监管协调倡议：改进和统一的机会。
Int J Health Policy Manag. 2024;13:8070. doi: 10.34172/ijhpm.2024.8070. Epub 2024 May 5.
6
Strengthening access to cancer medicines for children in East Africa: policy options to enhance medicine procurement, forecasting, and regulations.加强东非儿童获得癌症药物的机会：增强药物采购、预测和监管的政策选择。
Glob Health Res Policy. 2024 Jul 1;9(1):24. doi: 10.1186/s41256-024-00365-y.
7
Identifying and costing common gaps in Central and West Africa pharmaceutical regulation.识别并计算出中非和西非药品监管中常见的差距及成本。
Front Med (Lausanne). 2024 Apr 5;11:1362253. doi: 10.3389/fmed.2024.1362253. eCollection 2024.
8
Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs: experiences of the WHO and Swissmedic.监管机构合作培训作为加强低收入和中等收入国家监管体系的一种方法：世界卫生组织和瑞士药品监管局的经验
Front Med (Lausanne). 2023 May 18;10:1173291. doi: 10.3389/fmed.2023.1173291. eCollection 2023.
9
Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.制药行业对西非国家经济共同体药品监管协调倡议的有效性和效率评估。
Front Pharmacol. 2023 May 9;14:1184108. doi: 10.3389/fphar.2023.1184108. eCollection 2023.
10
Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.非洲药品监管协调倡议中的最佳实践：监管机构与药品制造商的观点
PLOS Glob Public Health. 2023 Apr 26;3(4):e0001651. doi: 10.1371/journal.pgph.0001651. eCollection 2023.
Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
监管要求对非洲国家药品注册的影响——南非制药公司的看法与经验
South Med Rev. 2012 Jul;5(1):31-7. Epub 2012 Jul 23.
4
Access to AIDS medicines stumbles on trade rules.获取艾滋病药物因贸易规则而受阻。
Bull World Health Organ. 2006 May;84(5):342-4. Epub 2006 May 17.